Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

Background and Aim. EGFR is commonly expressed in cancers of the head and neck (H and N), and anti-EGFR agents have demonstrated improvements in outcomes (TTP and OS). The aim of this study was to determine EGFR gene status in H and N cancer patients treated with gefitinib and to correlate mutationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Samuel, Bobos, Mattheos, Angouridakis, Nikolaos, Nikolaou, Angelos, Linardou, Helena, Razis, Evangelia, Fountzilas, George
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022192/
https://www.ncbi.nlm.nih.gov/pubmed/21274259
http://dx.doi.org/10.1155/2010/709678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022192/
https://www.ncbi.nlm.nih.gov/pubmed/21274259
http://dx.doi.org/10.1155/2010/709678

Ejemplares similares